Key Discovery Solves Long-Standing Baffling Mystery of Gulf War Syndrome in Veterans
Landmark discovery solves baffling mystery around Gulf War Illness in veterans
Approval of bimekizumab in the United States, an IL-17 A and F blocker with European approval for psoriatic arthritis. Dermatologists now have a range of choices for highly effective and safer options, both in biologics and orals.